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Bacterial toxin-antitoxin (TA) systems serve a variety
of physiological functions including regulation of
cell growth and maintenance of foreign genetic
elements. Sequence analyses suggest that TA fami-
lies are linked by complex evolutionary relationships
reflecting likely swapping of functional domains
between different TA families. Our crystal structures
of Phd-Doc frombacteriophageP1, theHigAantitoxin
from Escherichia coli CFT073, and YeeU of the
YeeUWV systems from E. coli K12 and Shigella
flexneri confirm this inference and reveal additional,
unanticipated structural relationships. The growth-
regulating Doc toxin exhibits structural similarity to
secretedvirulence factors that are toxic for eukaryotic
target cells. The Phd antitoxin possesses the same
fold as both the YefM and NE2111 antitoxins that
inhibit structurally unrelated toxins. YeeU, which has
an antitoxin-like activity that represses toxin expres-
sion, is structurally similar to the ribosome-interacting
toxins YoeB and RelE. These observations suggest
extensive functional exchanges have occurred
between TA systems during bacterial evolution.
INTRODUCTION
Microbial toxin-antitoxin (TA) systems are employed by
bacterial, bacteriophage, and autonomous extrachromosomal
DNA elements to regulate bacterial growth. Plasmid- and
phage-encoded TA systems serve as ‘‘addiction modules’’ that
maintain their genetic material within host cells by exerting996 Structure 18, 996–1010, August 11, 2010 ª2010 Elsevier Ltd Allbacteriostatic/bacteriocidal effects. Chromosomal TA systems
are thought to reversibly attenuate bacterial growth under
conditions of nutritional or environmental stress (Condon,
2006). The vast majority of TA systems are believed to employ
a commonmechanism of action in which proteolytic degradation
of the antitoxin allows the toxin to kill the cell or send it into
a quiescent state. For chromosomal systems, removal of the
environmental stressor allows newly synthesized antitoxin to
complex with the existing toxin, thus reversing toxicity and
allowing resumption of normal growth. This process may
become bacteriocidal under conditions in which the quiescent
state can no longer be maintained or the ability to synthesize
new antitoxin is lost (Pedersen et al., 2002). For plasmid-en-
coded systems, toxicity occurs when a daughter cell is cured
of the foreign genetic element and loses the ability to synthesize
new antitoxinmolecules. As the existing antitoxins are degraded,
toxin activity results in irreversible postsegregational killing of the
cured cell. Consequently, the killing of cured cells maintains
phage or plasmid DNA in bacterial populations.
Valuable insight into the structure and function of TA systems
has been gained from the crystal structures of individual toxin
and antitoxin molecules (Hargreaves et al., 2002; Kamada and
Hanaoka, 2005; Loris et al., 1999, 2003), complete TA com-
plexes (Kamada and Hanaoka, 2005; Kamada et al., 2003;
Mattison et al., 2006; Miallau et al., 2009; Takagi et al., 2005),
and complexes of toxins with their cellular targets (Dao-Thi
et al., 2004; Kamphuis et al., 2006). These structures have
revealed information on toxin-antitoxin complex assembly,
how antitoxins inhibit their toxin partners, and details on the
mechanisms of toxin activity. In particular, the structures of the
YoeB-YefM (Kamada and Hanaoka, 2005) and RelBE systems
(Takagi et al., 2005) have revealed that the YoeB and RelE toxins,
despite sharing only 13% sequence identity, are structurally
similar to one another and have a similar fold to a family of micro-
bial RNases (Kamada and Hanaoka, 2005). Amino acid residuesrights reserved
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Homologies between Different Bacterial TA Systemsimplicated in the function of the toxins and related RNases are
clustered on one face of the central b sheet that forms the core
of these enzymes, although the specific locations of the catalytic
residues are not conserved.
There is considerable functional diversity even among struc-
turally related toxins. Many inhibit protein synthesis and can be
broadly classified as either ribosome-dependent or ribosome-
independent mRNA interferases (Yamaguchi and Inouye, 2009;
Zhang et al., 2009). The structurally unrelated Doc and YoeB
toxins are ribosome-dependent mRNA interferases that inhibit
protein translation using different mechanisms. Doc, an a-helical
bundle protein, interacts with the 30S ribosomal subunit and
blocks translation (Liu et al., 2008) whereas YoeB, which has
a microbial RNase fold, interacts with the 50S ribosomal subunit
and prevents translation initiation (Zhang and Inouye, 2009).
RelE, which is structurally similar to YoeB, is also a ribosome-
dependent mRNA interferase that cleaves mRNA positioned in
the ribosomal A site (Pedersen et al., 2003). HigB, which is
homologous to RelE and YoeB (Pandey and Gerdes, 2005),
is a sequence-specific endoribonuclease whose activity is
dependent on association with the 50S ribosomal subunit
(Christensen-Dalsgaard and Gerdes, 2006; Hurley andWoychik,
2009). MazF, a ribosome-independent mRNA interferase,
cleaves single-stranded RNA, specifically recognizing the
sequence ACA (Zhang et al., 2003). TheMazF structure (Kamada
et al., 2003) revealed that it is homologous to two other toxins:
Kid/PemK of the R100 plasmid and CcdB of the F plasmid.
Whereas the MazF and Kid toxins have similar biochemical
functions as sequence-specific, ribosome-independent mRNA
interferases (Zhang et al., 2004), CcdB instead inhibits DNA
replication by binding to DNA gyrase (Miki et al., 1992).
In contrast to toxins, antitoxin function is relatively invariant
despite dramatic differences in the sequences and folds of
antitoxins from different families. Antitoxins are composed of
two domains which have distinct functions. The ‘‘neutralization’’
domainbinds to the toxin andneutralizes it, either byoccluding its
active site (Kamada and Hanaoka, 2005; Kamada et al., 2003;
Miallau et al., 2009) or by changing its shape such that it can no
longer interactwith its cellular target (Garcia-Pino et al., 2008; Ta-
kagi et al., 2005). The other domain is a DNA-binding domain that
represses transcription by binding near the promoter of the
operon encoding the TA complex. This repression is typically
mediated by the complete TA complex, although it can be
mediated by the antitoxin alone (Kedzierska et al., 2007).
To date, there is only one TA system in which an antitoxin-like
activity hasdeviated from this general schemeof toxin neutraliza-
tion and transcriptional autoregulation. YeeU of the YeeUV(W) TA
system appears to inhibit the toxicity of the YeeV toxin without
directly binding to it. YeeU is believed to function as either a tran-
scriptional or translational attenuator of YeeV expression, by
binding to a short (70 bp) nucleotide sequence between the
yeeU and yeeV genes (Brown and Shaw, 2003). YeeU represents
the first example where a proteinaceous antitoxin controls toxin
activity solely via regulation of toxin expression without directly
binding to the toxin to neutralize it. The function of YeeW, the
product of the third gene in the yeeUVW operon, is unknown.
Many bacteria harbor an abundance of chromosomal TA
systems. The Escherichia coli genome encodes at least seven
systems from six different sequence families, whereas theStructure 18, 996Mycobacterium tuberculosis genome encodes a minimum of
57 TA systems, many from the VapBC family (Makarova et al.,
2009). Sequence-profiling analyses suggested that there are
four major families of TA systems that evolved independently
(Anantharaman and Aravind, 2003; Pandey and Gerdes, 2005),
along with an abundance of subfamilies that resulted from the
swapping of individual components (either toxin or antitoxin
genes) or domains of these components between the major
families (Smith andMagnuson, 2004). A more recent study using
a combination of sequence analysis methods found many new
families of TA systems that had not been described previously
(Makarova et al., 2009). Some of these new families were specific
to certain lineages of archaea or eubacteria. In some instances,
toxins or antitoxins from known families were found to exist in the
absence of their cognate partner, such as, for example, the
Myxococcus xanthus MazF gene, which is not cotranscribed
with its cognate antitoxin (Nariya and Inouye, 2008). Although
the functions of these ‘‘solo’’ components have yet to be
investigated experimentally, Makarova et al. hypothesized that
they would most likely have biochemical activities similar to the
homologs found within canonical two-component TA systems.
Specifically, they proposed that the transcriptional regulation
activity of solo antitoxins would regulate expression of particular
genes, whereas solo toxins would continue to target particular
biochemical processes potentially modulating cellular growth.
The evolutionary relationships between TA systems, as pre-
dicted by phylogenetic analyses, have been confirmed in part
by crystallographic studies showing structural similarities
between YoeB and RelE (Kamada and Hanaoka, 2005) and
between the Kis, CcdB, and MazF toxins (Kamada et al.,
2003). However, additional structural information is needed to
elucidate these complex relationships.
We herein prove additional structural relationships between
TA systems. We have determined crystal structures of the P1
bacteriophage toxin Doc (death on curing) in complex with its
antitoxin Phd (prevents host death), of the HigA antitoxin of the
HigBA TA system, and of the YeeU protein of the YeeUV(W) TA
system. These structures all establish homology to components
from different TA systems. The structure of Phd is observed to be
homologous to an antitoxin that neutralizes a toxin with a related
endonuclease activity but a structure unrelated to Doc, thereby
proving that shuffling of antitoxins between different TA systems
occurred over the course of evolution. The structure of the HigA
antitoxin demonstrates a complementary form of shuffling by
showing that different antitoxin folds are used to neutralize
homologous YefM/YoeB-family toxins. The structure of the
YeeU antitoxin demonstrates a third kind of evolutionary rela-
tionship between TA systems. Although YeeU has a fold related
to the YoeB/RelE nucleic acid-hydrolyzing toxins, YeeU is
a nucleic acid-binding factor with antitoxin-like activity, suggest-
ing evolutionary exchange between toxin and antitoxin families.
Our results thus clarify the complex evolutionary relationships
underlying the proliferation of TA systems.
RESULTS AND DISCUSSION
Phylogenetic Relationships between TA Systems
Figure 1 presents a series of cladograms summarizing the likely
evolutionary relationships between TA system components–1010, August 11, 2010 ª2010 Elsevier Ltd All rights reserved 997
Figure 1. Evolutionary Relationships between Components of Bacterial Toxin-Antitoxin Systems
Cladograms modeling the evolutionary relationship between a representative member of toxin (left) and antitoxin (right) families were prepared using MEGA
(as described in Experimental Procedures). Structurally related proteins are grouped together into single cladograms. The double-headed arrows connect
cognate toxins and antitoxins from representative TA systems. Branches of families that have a member whose structure has been experimentally determined
are labeled in red.
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Homologies between Different Bacterial TA Systemsrelated to the crystal structures presented in this paper. These
relationships were inferred from structural similarity combined
with sequence profiling of predicted protein families from 474
fully sequenced microbial genomes. Homologous proteins
were split into putative functional families based on simulta-
neous occurrence of two homologs in a single genome (S.K.H.
and J.F.H., unpublished data). Earlier sequence-profiling
analyses predicted that many families of TA systems are evolu-
tionarily related to one another and that functional protein
domains have been exchanged between different TA systems
(Anantharaman and Aravind, 2003; Makarova et al., 2009; Smith
and Magnuson, 2004). Our sequence-profiling analyses corrob-
orate most of these results, correctly linking the structurally
related RelE/YoeB toxins (Figure 1) and MazF/Kid/CcdB toxins
(not shown). Although earlier studies also predicted homology
between PhD, YefM, and some VapC-neutralizing antitoxins
(Anantharaman and Aravind, 2003; McKinley and Magnuson,
2005), the similarity levels between these different families
were statistically unconvincing in our sequence-profiling anal-
yses. However, the crystal structure of the PhD-Doc complex998 Structure 18, 996–1010, August 11, 2010 ª2010 Elsevier Ltd Allreported in this paper (Table 1 and Figures 2 and 3) unambigu-
ously proves this relationship, showing that the DNA-binding
domain of PhD has the same fold as that of YefM. In addition,
the crystal structures of YeeU presented in this paper establish
that YeeU, which possesses antitoxin-like activity (Brown and
Shaw, 2003), has a similar structure to RelE/YoeB-family toxins.
This result suggests an evolutionary relationship between func-
tionally antithetical YeeU-family antitoxins and RelE/YoeB-family
toxins, even though they do not exhibit significant sequence
similarity. Proteins from families related by statistically significant
sequence or structural similarity were combined into sequence
profiles to identify the final set of homologous families shown
in Figure 1.
Experimental structure determination has proven to be
a critical tool, not only in helping to elucidate the function of
some TA systems (Kamada and Hanaoka, 2005; Kamada
et al., 2003; Mattison et al., 2006; Miallau et al., 2009; Takagi
et al., 2005) but also in confirming evolutionary relationships
linking apparently disparate systems. In addition to establishing
clear structural similarity between proteins exhibiting weak orrights reserved
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bacteria, as cited above, earlier structural results have confirmed
the prediction that RelE toxins could be neutralized by antitoxins
from unrelated families (Anantharaman and Aravind, 2003;
Makarova et al., 2009) (Figure 1). M. tuberculosis RelE
(Rv2866) forms a complex with a YefM-like antitoxin (M. tubercu-
losis RelB, Rv2865, Protein Data Bank [PDB] ID code 3G5O),
whereas the E. coli RelE is neutralized by an antitoxin (E. coli
RelB, PDB ID code 2K29)with a completely different fold (Li et al.,
2008, 2009; Takagi et al., 2005). The structure of Phd presented
in this paper (Table 1 and Figures 2 and 3) confirms a prediction
that the YefM-like antitoxin fold has been adapted to neutralize
toxins with different folds (Anantharaman and Aravind, 2003;
Makarova et al., 2009). The structures of YeeU presented in
this paper (Table 1) extend the impact of structural results on
TA biology in two new ways. First, they demonstrate that some
homologies between TA systems have not been detected using
existing sequence-profiling methods (Altschul et al., 1997).
Second, they demonstrate that the component of the YeeUV
(W) system with antitoxin activity (Brown and Shaw, 2003) has
significant structural similarity to the RelE/YoeB toxin fold. This
observation, which represents the first report of a structural
relationship between toxin and antitoxin species, shows that
a single nucleic acid-binding fold has been adapted to perform
both growth-inhibiting toxin functions and an expression-regu-
lating antitoxin function. Therefore, our results on YeeU highlight
the importance of experimental structure determination in
elucidating the complex evolutionary relationships between
components of different TA systems.
Crystal Structure of the Complete Phd-Doc Complex
Our crystal structure of the Phd-Doc complex contains a 2:2
Phd-Doc heterotetramer (Figure 2 and Table 2). Each Doc toxin
is bound to a single Phd antitoxin, and the resulting Phd-Doc
complex dimerizes based exclusively on contacts between
two Phd molecules. Several analytical methods indicate that
Phd-Doc tends to adopt a heterogeneous aggregation state in
solution (our data and Gazit and Sauer, 1999a) but that the
2:2 oligomer is likely to be the dominant species in our Phd-Doc
preparation. Coomassie blue staining of SDS-PAGE gels (e.g.,
as shown in the inset in Figure S1 available online) shows
a roughly equal stoichiometry of Phd and Doc in the stock
produced by our two-step purification procedure, which
involves Ni-NTA affinity chromatography of His6-tagged Doc
followed by preparative gel-filtration chromatography. Analyt-
ical gel-filtration chromatography of this preparation monitored
using inline static-light-scattering and refractive-index detectors
(Figure S1) shows heterogeneity in oligomeric state, including
some higher-order oligomers and a minor trailing shoulder likely
containing a 2:1 Phd-Doc complex (based on its measured
molecular weight of 30 kDa versus 30,839 kDa predicted).
However, the bulk of the protein mass is observed in a larger
complex with mean molecular weight of 37 kDa, which
is consistent with an equilibrium between 2:2 and 2:1 Phd-
Doc complexes after 10-fold dilution of the crystallization
stock coming through the gel-filtration column. Therefore, the
undiluted stock is likely to be dominated by the larger oligomer
observed in our crystal structure. Nonetheless, the heteroge-
neous aggregation state of Phd-Doc and its smaller 2:1Structure 18, 996complex may have biological significance in modulating the
dynamics of toxin activation, as discussed in Supplemental
Information.
In contrast to the previously reported Phd52–73-Doc structure
(Garcia-Pino et al., 2008), which contained only the C-terminal
neutralization domain of Phd, our complex structure contains
the full-length Phd-Doc complex (Figure 2) and shows unambig-
uous electron density for 72 of the 73 residues in Phd, with only
its N-terminal methionine being disordered. This structure
confirms the inference that Phd has a modular structure
(McKinley and Magnuson, 2005; Smith and Magnuson, 2004)
because its N-terminal DNA-binding domain does not make
any noncovalent packing interactions with its C-terminal neutral-
ization domain. The structure shows no significant conforma-
tional differences in Doc compared to the previously reported
structure in complex with Phd52–73 (Garcia-Pino et al., 2008).
Our structure shows electron density for 123 (chains C and D)
or 124 residues (chains A andB) out of 126 total in Doc; the previ-
ously reported structure similarly has electron density for 123
residues, with 2 or 3 C-terminal residues and the hexahistidine
tag being disordered in the crystal lattice.
Doc is a helical-bundle protein composed of six a helices.
The Doc fold has yet to be classified in the SCOP protein fold
database (Murzin et al., 1995), but Doc exhibits structural simi-
larity to the Fic protein (Garcia-Pino et al., 2008) and AvrB,
a secreted bacterial toxin (Kinch et al., 2009). Both of these
homologous proteins interact with nucleotides (Table 1). Two
residues essential for Doc activity (Magnuson and Yarmolinsky,
1998), His-66 and Asp-70, are positioned in a surface-exposed
loop connecting a helices 3 and 4. There is clear evidence that
the side chain of this histidine is mobile in our structure because
it shows electron density for two conformations in all of the
crystallographically independent subunits of Doc (data not
shown). The substitution of this histidine for tyrosine does not
significantly affect the structure, as superposition of our struc-
ture with that previously reported for the H66Y mutant of Doc
(Garcia-Pino et al., 2008) reveals that the histidine and tyrosine
side chains occupy the same physical location. Moreover, the
two structures show no qualitative conformational difference
(0.9 A˚ root-mean-square deviation [rmsd] for superposition of
123Ca atoms). Our Doc structure has a spontaneously occurring
F68S mutation in the same loop containing H66. Although this
mutation does not significantly perturb backbone conformation
compared to the previously reported structure with the wild-
type phenylalanine residue at position 68, it may have been
selected during plasmid propagation because it attenuates
Doc toxicity. Such an effect would not be surprising, given the
fact that the amino acids at the2 (His-66) and +2 (Asp-70) posi-
tions in the same loop are essential for activity.
The structure of the N-terminal DNA-binding domain of Phd
(Figure 2; Figure S1) has the following topology: b1 (residues
3–5) followed by kinked a helix, a1 (residues 6–11, 13–22), b2
(residues 26–29), b3 (residues 36–40), and a second kinked
a helix, a2 (residues 41–62, 64–72). The three b strands of Phd
form an antiparallel b sheet which makes a six-stranded b sheet
via dimerization of the two Phd subunits (Figures 2 and 3). The
bottom surface of the Phd N-terminal DNA-binding domain has
an intense patch of positive electrostatic potential (Figure 2D)
that is a common characteristic of DNA-binding proteins.–1010, August 11, 2010 ª2010 Elsevier Ltd All rights reserved 999
Table 1. Structural Similarity of Phd-Doc, HigA, and YeeU
Protein/Organism
PDB
ID Code Z Score RMSD
Number
Alignedb
Sequence
Identity (%)
Dali
Rank Function SCOP Family
Proteins with a Similar Structure to Doc
Fic-domain-
containing protein:
Bacteroides
thetaiotaomicron
3CUC 7.5 3.2 116 (268) 16 11 Function not
determineda
Fic-like
AvrB: Pseudomonas
syringae
1NH1 7.4 3.6 110 (290) 11 12 Membrane-
associated
toxin that targets
host immune
resistance
proteins
Antivirulence
factor (fold
and family are
the same)
Fic: Neisseria
meningitidis
2G03 6.7 3.1 105 (177) 15 17 Function not
determineda
Fic-like
Fic: Helicobacter
pylori
2F6S 6.5 3.1 106 (180) 13 20 Function not
determineda
Fic-like
Cytotoxin L:
Clostridium sordellii
2VKH 4.4 4.6 79 (533) 6 63 ‘‘Lethal toxin’’ that
targets Rho GTPases
of the mammalian
host
Nucleotide-
diphospho-
sugar
transferases
d-endotoxin CryIIIA:
Bacillus thuringiensis
1DLC 2.4 5.0 84 (584) 12 Pore-forming toxin
that disrupts gut
epithelia membranes
Toxins’
membrane
translocation
domains
(N-terminal
domain)
Proteins with a Similar Structure to Phd
YefM (Rv2865): M.
tuberculosis
3G5O 6.3 3.1 58 (92) 21 1 Antitoxin protein that
neutralizes RNA-
degrading RelE toxin
YefM-like
YefM (Rv3357): M.
tuberculosis
3CTO 7.3 2.4 55 (65) 25 3 Antitoxin protein that
neutralizes RNA-
degrading YoeB toxin
YefM-like
YefM: E. coli 2A6Q 7.3 1.6 52 (58) 25 5 Antitoxin protein that
neutralizes RNA-
degrading YoeB toxin
YefM-like
NE2111:
Nitrosomonas
europaea
2ODK 6.6 1.7 49 (50) 27 15 Putative antitoxin
protein of predicted
YefM-FitB TA system
YefM-like
Proteins with a Similar Structure to YeeU
YeeU: Shigella
flexneri
2INW 20.7 0.8 104 (116) 93 3 Putative antitoxin
protein of the YeeU-
YeeV TA system
Profilin-like
YfjZ: E. coli 2EA9 17.5 1.2 99 (103) 62 5 Putative antitoxin of
the predicted YpjF-
YfjZ TA system
Profilin-like
RelE: Pyrococcus
horikoshii
1WMI 4.0 3.5 69 (88) 7 182 RNA-degrading
toxin of RelBE TA
system
RelE-like
RelE: E. coli 2KC8 3.4 3.6 67 (95) 7 316 RNA-degrading
toxin of RelBE TA
system
(Pending)
RelE: M. jannaschii 3BPQ 2.7 4.1 61 (85) 7 421 RNA-degrading toxin
of RelBE TA system
(Pending)
RelE: M. tuberculosis 3G5O 2.9 3.5 62 (81) 10 434 RNA-degrading toxin
of YefM-RelE TA
system
(Pending)
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Table 1. Continued
Protein/Organism
PDB
ID Code Z Score RMSD
Number
Alignedb
Sequence
Identity (%)
Dali
Rank Function SCOP Family
YoeB: E. coli 2A6S 3.0 3.2 61 (84) 7 436 RNA-degrading
toxin of YefM-
YoeB TA system
RelE-like
Proteins with a Similar Structure to HigA
YbaQ: E. coli 2EBY 13.2 2.7 89 (102) 29 3 Putative HTH-type
transcriptional
regulator
(Pending)
Putative antidote
protein: Nostoc
punctiforme
PCC 73102
3CEC 12.9 5.1 88 (91) 26 5 Putative antidote
protein of TA
system
(Pending)
DNA-binding
domain of C2
repressor:
Salmonella
bacteriophage
P22
1ADR 8.4 1.9 67 (76) 16 6 HTH-type
transcriptional
regulator
l repressor-like
DNA-binding
domains
DNA-binding
domain of C1
repressor:
bacteriophage
434
1R69 8.1 1.6 62 (63) 18 10 HTH-type
transcriptional
regulator
l repressor-like
DNA-binding
domains
E. coli MqsA
antitoxin (YgiT/
b3021)
3GN5 4.5 2.6 54 (132) 19 218 HTH-type
transcriptional
regulator
(Pending)
a Fic domains have been shown to mediate bacterial pathogenicity by adenylation of host-cell proteins.
b The number in parentheses indicates the total length of the similar structure.
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Homologies between Different Bacterial TA SystemsGenetic studies havedetermined that theC-terminal domain of
Phd (amino acids 52–73) is the minimal unit of Phd required for
Doc inhibition (McKinley and Magnuson, 2005; Smith and Mag-
nuson, 2004). Our structure, combined with that of Loris and
coworkers (Garcia-Pino et al., 2008), explains the structural basis
for this observation. The C terminus of Phd (residues 52–73)
adopts a kinked a-helical conformation. Amino acids 54–62 are
predominately hydrophobic and pack into a hydrophobic groove
onDoc; the kink in thePhdhelix allowschargedaminoacids in the
distal portion of the C terminus to interact with charged residues
on an adjacent face of Doc (Figures 2B, 2C, and 3C). Residues
His-66 and Asp-70, which are required for Doc activity, are not
occluded by binding of the Phd antitoxin (Figure 2B). As noted
(Garcia-Pino et al., 2008), this observation suggests that Phd
may inhibit Doc toxicity indirectly bymaking the complex so large
that steric hindrance prevents Doc from binding to its target site
on ribosomes. A similar inhibitory mechanism has previously
been proposed for the RelBE TA complex (Takagi et al., 2005).
Homologs of Phd
The program Dali was used to search the Protein Data Bank for
proteins with structural similarity to Phd (Table 1), and the top
four results were all proteins annotated as antitoxins: the YefM
antitoxin of the E. coli YefM-YoeB TA system (PDB ID code
2A6Q, Z score of 7.3 and 1.6 A˚ rmsd for alignment of 52 residues
with 25% sequence identity) (Figures 3A and 3B); protein Rv3357
fromM. tuberculosis (PDB ID code 3CTO, Z score of 7.3 and 2.4 A˚
rmsd for alignment of 55 residues with 25% sequence identity);Structure 18, 996–protein NE211, a putative prevents host death (Phd) protein,
from Nitrosomonas europaea (PDB ID code 2ODK, Z score of
6.6 and 1.7 A˚ rmsd for alignment of 49 residues with 27%
sequence identity); and protein Rv2865 from M. tuberculosis
(PDB ID code 3G5O, Z score of 6.3 and 3.1 A˚ rmsd for alignment
of 58 residues with 21% sequence identity). The structures of
NE211andRv3357 (Kumaretal., 2008)donotcontain thecognate
toxins, whereas the structure ofM. tuberculosis Rv2865 antitoxin
wasdeterminedasacomplexwith theRv2866 toxin,whichhasan
equivalent backbone fold to that of the RelE and YoeB toxins. The
YefM and NE2111 proteins are classified by the SCOP database
as having a YefM-like fold and, based on the high degree of struc-
tural similarity (Figures 3A and 3B), it is likely that the other three
homologous antitoxins would also be classified as YefM-like
folds. Sequence-profiling analyses had predicted that the Phd
and YefM antitoxins are homologous to one another (Ananthara-
man and Aravind, 2003; McKinley and Magnuson, 2005); our
crystal structure of Phd proves that this inference is correct.
The strong conservation of the N-terminal DNA-binding
domain of these homologous antitoxins is consistent with its
function in regulating expression of the corresponding TA
complexes. Although repression of both Phd-Doc and YefM-
YoeB transcription is enhanced by the binding of the complete
TA complex to its operator (Kedzierska et al., 2007; Magnuson
and Yarmolinsky, 1998), the minimal requirement for repression
is a dimer of the conserved N-terminal DNA-binding domain
(Gazit and Sauer, 1999b; Kedzierska et al., 2007; Smith and
Magnuson, 2004). All four of the homologous antitoxins form1010, August 11, 2010 ª2010 Elsevier Ltd All rights reserved 1001
Figure 2. The Structure of the Heterotetra-
meric Phd-Doc Complex
(A) Stereo view of the 2:2 Phd-Doc complex. Phd
molecules are colored green and brown, while
Doc molecules are colored blue and dark teal.
(B) Another stereo view of the 2:2 Phd-Doc
complex highlighting the Phd-Doc interactions
(rotated 90 around a horizontal axis compared
with the view in A). Charged residues in the Phd
neutralization domain that interact with charged
Doc residues are shown in stick representation.
Residues implicated in Doc function (His-66,
Asp-70) are colored yellow and orange for contrast
and are shown in stick representation.
(C) Surface representation of Doc colored accord-
ing to electrostatic potential, with blue and red,
respectively, representing surface potentials of
5 kT and 5 kT in 100 mM salt (oriented as in B).
Charged residues in the neutralization domain of
Phd are shown in stick representation.
(D) Two views of the molecular surface of the Phd-
Doc complex colored by electrostatic potential
using the same parameters. The left panel is in
the same orientation as (A), whereas the right
panel is rotated 180 compared to the view in (B).
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Homologies between Different Bacterial TA Systemssimilar homodimer structures with at least 1200 A˚2 of solvent-
accessible surface area per protomer buried in the intersubunit
interface (1393 A˚2 for Phd, 1397 A˚2 for E. coli YefM, 1240 A˚2
for NE2111, 1333 A˚2 for Rv2865, and 1235 A˚2 for Rv3357) (Kris-
sinel and Henrick, 2007). The critical elements for regulation of
TA operon expression thus reside in the DNA-binding domain
of the Phd/YefM antitoxins, explaining the conservation and
proliferation of this domain in multiple TA subfamilies.
The Phd/YefM Fold Has Been Adapted for Neutralization
of Structurally Unrelated Toxins
Sequence analysis studies have suggested that gene duplication
and recombination events fused the Phd DNA-binding domain
with the neutralization domain of structurally distinct antitoxins,
thus creating new chimeric TA systems (McKinley andMagnuson,
2005; Smith andMagnuson, 2004). Our Phd-Doc crystal structure
supports the hypothesis that antitoxin modules have been swap-
ped between structurally and functionally distinct toxin systems
in the course of bacterial evolution. Whereas the N-terminal1002 Structure 18, 996–1010, August 11, 2010 ª2010 Elsevier Ltd All rights reservedDNA-binding module is conserved in all of
the antitoxins related to PhD and YefM,
the toxin neutralization domain varies in
both sequence and length (Figure S2).
These sequence differences presum-
ably reflect evolutionary adaptations
necessary for high-affinity interaction with
structurally distinct toxins. The Doc toxin
has an all-a-helical fold that differs from
the YoeB/RelE fold, which has a central
b sheet flanked by a helices (Figures 3D).
There is no structure available for NE2112,
but sequence analyses suggest that this
protein has a fold related to that of the
FitB/VapC toxin family, which is differentfrom that of either Doc or YoeB/RelE. A PSI-BLAST search of the
Protein Data Bank reveals that NE2112 has 32% identity to FitB
from Neisseria gonorrhoeae (PDB ID code 2H1C) (Mattison et al.,
2006), 25% identity to M. tuberculosis VapC-5 (protein Rv0627,
PDB ID code 3DBO), and 20% identity with another VapC-family
toxin from M. tuberculosis (protein Rv0301, PDB ID code 3H87).
Secondary-structure prediction using the PredictProtein server
(Rost et al., 2004) indicates a high probability that NE2112 has an
equivalent a/b/a secondary structural organization to these
proteins (data not shown). Antitoxins homologous to Phd thus
neutralize toxins with at least three different folds (Figure 1). The
structural differences between the Doc, RelE/YoeB, and NE2112
toxins lead to substantial differences in their structural interactions
with the neutralization domains of the corresponding Phd/YefM-
like antitoxins, as detailed in Supplemental Information.
Homologs of Doc
An evolutionary relationship between the Doc toxin and the Fic
family of proteins has recently been proposed based on
Figure 3. Homologous Phd/YefM/NE2111 Antitoxins Neutralize
Toxins with Disparate Folds
(A and B) Stereo view of the superposition of Phd with EcYefM and NE2111
antitoxins. In (A), Phd is in the same orientation as in Figure 2A, whereas in
(B), the antitoxins are rotated by 90. The DNA-binding domains are in green
(Phd), yellow (EcYefM), and orange (NE2111) while the toxin neutralization
domains of Phd and EcYefM are colored blue and red, respectively.
(C) The interaction of the Phd neutralization domain (in yellow, residues 52–73)
with Doc (colored dark teal).
(D) Interaction of the EcYefM neutralization domain (in red, residues 61–92)
with YoeB (colored yellow).
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Homologies between Different Bacterial TA Systemssequence (Figure 4A) and structural (Figures 4B and 4C) simi-
larity (Garcia-Pino et al., 2008; Kinch et al., 2009). Whereas early
studies suggested that Fic proteins function in bacterial cell divi-
sion (Kawamukai et al., 1988; Komano et al., 1991), recent work
has demonstrated that pathogenic bacteria export Fic-domain-
containing proteins into the cytosol of host cells, where they
act as toxinsmodifying and inactivating critical host-cell proteins
(Yarbrough et al., 2009). A bioinformatics study has proposed
that the Fic domains share a common ancestor with Doc and
AvrB, another secreted toxin involved in bacterial pathogenesis
(Lee et al., 2004), and that these proteins constitute the ‘‘Fido’’
protein superfamily (Kinch et al., 2009).
A Dali search confirmed that the most closely related proteins
to Doc (Table 1) are Fic-domain-containing proteins and Pseu-Structure 18, 996–domonas syringae AvrB (PDB ID code 1NH1) (Lee et al., 2004)
(Figures 4B and 4C). This search also showed weaker but none-
theless significant structural similarity to domains from a number
of substantially larger secreted bacterial toxins, including the
‘‘lethal toxin’’ from Clostridium sordellii (Table 1). These struc-
tural comparisons, which are discussed in greater depth in
Supplemental Information, suggest complex evolutionary rela-
tionships between the growth-regulating toxins related to Doc
and many different families of secreted toxins that kill eukaryotic
target cells during bacterial pathogenesis.
Superimposing Doc with AvrB (Figures 4B and 4C) provides
insight into possible functional features underlying the evolu-
tionary relationships between proteins from different branches
of the Fido-domain family. The structural similarity between
these proteins spans most of the a-helical bundle formed by
Doc (Z score of 7.4 and 3.6 A˚ rmsd for alignment of 110 resi-
dues with 11% sequence identity). AvrB has two domains,
a smaller mixed-a/b domain and a larger a-helical bundle
domain, separated by a substantial cleft. A mononucleotide-
binding site in AvrB, located on the upper face of the a-helical
bundle facing the cleft, mediates enzymatic phosphorylation of
target proteins. The structural similarity between Doc and AvrB
is restricted to the a-helical domain in AvrB, and Doc lacks the
small domain that covers the mononucleotide-binding site in
AvrB. This small domain presumably aids AvrB in catalyzing
target protein phosphorylation using bound ATP but, if present
in Doc, it would obscure His-66 and Asp-70 (Figures 4A and
4B), which have been proposed to interact with 16S rRNA
when Doc binds to ribosomes. Mutations in either of these
residues eliminate Doc toxicity (Magnuson and Yarmolinsky,
1998), and they have been hypothesized to contact rRNA
based on the observation that Doc interaction with ribosomes
is competitively inhibited by the aminoglycoside antibiotic
hygromycin B (Liu et al., 2008), which binds directly to 16S
rRNA near the decoding center of the ribosome (Brodersen
et al., 2000).
Importantly, His-66 and Asp-70, the putative rRNA-binding
residues in Doc, are conserved in other Fido-domain proteins,
including AvrB (Kinch et al., 2009). In this protein, they are
located proximal to the phosphates of its boundmononucleotide
(Figures 4A and 4B). This observation, combined with the
hypothesis that this region of Doc interacts with rRNA, provides
a possible functional explanation for the likely common evolu-
tionary ancestry of the secreted and growth-regulating toxins
from different branches of the Fido-domain family (Kinch et al.,
2009). Specifically, we propose that these proteins employ their
mutually conserved surface to interact with different nucleic acid
ligands and substrates. In AvrB, the conserved residues on this
surface contribute to recognition of the ribonucleotide ATP and
also likely catalysis of transfer of its g-phosphate group to target
host-cell proteins. The homologous Fic proteins are believed to
use an overlapping active site to catalyze covalent modification
of target proteins with AMP, again using an ATP substrate (Kinch
et al., 2009). In Doc, the equivalent residues presumably mediate
interaction with equivalent chemical moieties in rRNA, which of
course is a polymer of ribonucleotides. Although Doc is not
known to have catalytic activity, it conceivably could contribute
to a ribonucleotide-related activity as part of some supramolec-
ular complex.1010, August 11, 2010 ª2010 Elsevier Ltd All rights reserved 1003
Table 2. Phd-Doc, YeeU, and HigA Refinement Statistics
Bacteriophage
P1 Phd-Doc
E. coli
CFT073 HigA E. coliYeeU S. flexneri YeeU
Crystal Parameters
Space group P212121 C2 P21 P212121
Unit cell
parameters
(A˚) at 100K
95.9, 111.3, 118.8
(90, 90, 90)
90.5, 26.4, 39.5
(90, 91.5, 90)
54.3, 45.3, 60.2
(90, 109, 90)
31.5, 74.0, 110.7
(90, 90, 90)
Data quality
Resolution (A˚) 40.0–2.7 30.0–1.63 40.0–2.1 19.42–1.5
Rsym [IR 3s(I)] (%) 13.8 23.7 5.5 7.3
Mean redundancy 8.2 5.75 2.27 7.00
Completeness (all) (%) 91.2 98.5 99.1 97.1
(IR sI) (%) 80.5 85.8 91.0 79.8
Mean I/sI 18.2 17.57 15.6 24.9
Refinement Residuals
Rfree (%) 26.7 22.5 25.3 25.0
Rwork (%) 21.7 18.4 22.0 22.5
Model quality
Rmsd bond lengths (A˚) 0.007 0.005 0.006 0.006
Rmsd bond angles () 0.910 1.01 1.3 1.40
Ramachandran plot
Core 94.9 95.2 91.0 90.4
Allowed 4.9 4.8 9.0 9.6
Generously allowed 0.1 — — —
Model contents
Protein residues Doc: A1–124, B1–124,
C1–123, D1–123
PhD: E2–73, F2–73,
G2–73, H2–73
A1–94 A16–124,a
B15–118
A4–120,
B4–119
Waters 95 96 82 256
Cl 1 — 1 —
PO4 4 — — 1
Mg — — 2 —
Glycerol 3 — 1 —
PDB ID code 3KH2 2ICT 2H28 2INW
aResidues 123 and 124 of EcYeeU chain A belong to the affinity tag.
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Homologies between Different Bacterial TA SystemsCrystal Structure of HigA
The HigBA complex from E. coli CFT073 was subjected to
extensive crystallization screening, but the resulting crystals
contained only the HigA antitoxin. HigA is classified by the
SCOP database as having a l repressor-like DNA-binding
domain fold, and the HigA structure (Figure 5) shows a canonical
helix-turn-helix (HTH) DNA-binding fold consisting of five
a helices (a1–a5 at residues 9–20, 24–31, 35–43, 50–59, and
64–80, respectively). Themost relevant results from aDali search
were an E. coli DNA-binding protein, a putative antitoxin from
aNostoc punctiforme TA system, bacteriophage HTH-type tran-
scriptional regulators, and the E. coli MqsA antitoxin (Table 1).
Sequence-profiling studies suggest that HigB, the cognate
toxin of the HigA antitoxin, is evolutionarily related to the RelE/
YoeB toxin family and shares the same protein fold (Pandey
and Gerdes, 2005). The HigA structure therefore confirms the1004 Structure 18, 996–1010, August 11, 2010 ª2010 Elsevier Ltd Alinference that toxins from this single structural family are neutral-
ized by antitoxins from at least three different fold families, that
is, the HTH family represented by HigA, the nonglobular all-a-
helical family represented by PhRelB, and the YefM-like family
(Figure 1). These three antitoxin families all have members with
experimentally characterized structures, including the Phd and
HigA structures presented in this paper (Figures 2, 3, and 5).
The genes encoding HigBA have a different organization from
most TA systems, because the toxin precedes the antitoxin
gene and both genes have their own promoters. A similar orga-
nization is shared by the genes encoding the MqsR-MsqA TA
system, whose structure has recently been solved (Brown
et al., 2009). Notably, the C-terminal DNA-binding domain of
MqsA has anHTH fold that is structurally similar to the N-terminal
DNA-binding domain of HigA (Figure 5B). The MqsR toxin has
a RelE/YoeB-like fold, providing additional evidence thatl rights reserved
Figure 5. Structure of the HigA Antitoxin and Comparison
with the MqsA Antitoxin
(A) Stereo view of the E. coli CFT073 HigA antitoxin. Although HigA neutralizes
a toxin that is homologous to YoeB, it is structurally unrelated to the YefM anti-
toxin that neutralizes YoeB (see Figure 1).
(B) Stereo view of superimposed HigA and MqsA antitoxins. HigA and MqsA
have structurally similar HTH DNA-binding domains but structurally dissimilar
neutralization domains, even though they inhibit structurally homologous RelE/
YoeB-family toxins. Therefore, RelE/YoeB-family toxins are neutralized by
antitoxins from at least three fold families (YefM-like, HigA, and MqsA).
(C) Stereo view of amodel of the HigA antitoxin in complex with DNAgenerated
by superimposing HigA on the structure of the P22 c2 repressor protein in
complex with DNA (PDB ID code 2R1J).
Figure 4. Structural Similarity of Doc to the Secreted Toxin AvrB
(A) Stereo view of the putative Doc active site. Residues conserved among
Fido domains (Kinch et al., 2009) are colored magenta. Additional residues
identified by Magnuson and Yarmolinsky (1998) that effect Doc activity are
colored green, as is the F68S mutation present in our crystal structure.
Mutations at sites labeled in bold text greatly attenuate the toxicity of Docwhile
interfering (italics) or not interfering (nonitalics) with its regulatory activity. The
F68S mutation and additional sites that are conserved among Fido domains
are labeled in plain text. Structural alignment of AvrB (B and C) shows the resi-
dues conserved among Fido domains are proximal to its bound ADPmolecule
(shown in transparent space-filling representation).
(B) Stereo pair in the same orientation as (A) showing superposition of Doc
(dark teal) with AvrB (orange). The small domain in AvrB covering its mononu-
cleotide-binding site has been omitted to improve clarity.
(C) Stereo pair showing a different view of a superposition of the full AvrB
structure with Doc.
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Homologies between Different Bacterial TA SystemsRelE/YoeB-family toxins are neutralized by antitoxins belonging
to distinct fold families. In fact, although the DNA-binding
domains of HigA andMqsA share the same fold, their neutraliza-
tion domains have different folds. The N-terminal neutralization
domain of MqsA consists of a single a helix plus three b strands,
which form a continuous b sheet with the core b sheet in MqsR
that is shared by all RelE/YoeB-like toxin family members.
In contrast, the C-terminal neutralization domain of HigA isStructure 18, 996–composed of an a helix and a loop but does not have any b struc-
ture (Figure 5A). Given this structural difference, as well as the
different order in the polypeptide chain of their neutralization
versus DNA-binding domains, the HigA and MqsA antitoxins
themselves have significantly different structures even though
they share one structural domain. Therefore, RelE/YoeB-family1010, August 11, 2010 ª2010 Elsevier Ltd All rights reserved 1005
Figure 6. Comparison of the YeeU Antitoxin Structure to Related Structures
(A) The EcYeeU structure. The left side shows a YeeU stereopair with putative functional residues labeled and shown in stick representation. The middle panel
shows the electrostatic surface potential of YeeU, with blue and red, respectively, representing surface potentials of 9 kT and6.5 kT in 100mMsalt. The panel on
the right shows a surface representation of EcYeeU colored according to sequence conservation using ConSurf (Landau et al., 2005) with a set of 20 YeeU homo-
logs (including E. coli YafW and YfjZ) aligned by Clustal W (Larkin et al., 2007). Burgundy indicates a high degree of conservation whereas teal represents regions
of variable sequence. Yellow indicates regions where degree of conservation could not be assigned with confidence.
(B) Stereo pair of EcYeeU superimposed on PhRelE. Residues known to be involved in PhRelE function are labeled and shown in stick representation. Themiddle
and right panels show the molecular surface of PhRelE colored according to electrostatic surface potential and sequence conservation, respectively, using the
same parameters as for EcYeeU.
(C) Stereo pair of EcYeeU superimposed on EcYoeB. Residues known to be involved in EcYoeB function are labeled and shown in stick representation. The
middle and right panels show the molecular surface of EcYoeB colored according to electrostatic surface potential and sequence conservation, respectively,
using the same parameters as for EcYeeU.
Structure
Homologies between Different Bacterial TA Systemstoxins are neutralized by antitoxins from at least four distinct fold
families.
Crystal Structures of YeeU
YeeU is a single-domain protein with a core comprising a
noncontinuous five-stranded antiparallel b sheet (Figure 6A
and Figure S3). The topology of YeeU is as follows: b1 (residues
29–37), b2 (residues 40–42, 48–51), a1 (residues 56–79), b3 (resi-
dues 90–94), b4 (residues 97–102), and b5 (residues 109–116).
A kinked a helix is inserted between strands b2 and b3, and it
packs into a cavity on the back of the twisted b sheet. Strand
b2 is interrupted by a single turn of a 3/10 helix. The EcYeeU
and SfYeeU structures are highly similar (Z score of 20.7 and
0.8 A˚ rmsd for alignment of 105 residues), consistent with the1006 Structure 18, 996–1010, August 11, 2010 ª2010 Elsevier Ltd Al92% sequence identity between these proteins. (The EcYeeU
structure is used for the analyses reported in this paper.)
Structural Similarity of the YeeU Antitoxin to the Toxins
RelE and YoeB
The YeeUV TA system was identified based on a bioinformatics
analysis of the E. coli K12 genome for genes fulfilling several
standard criteria for TA systems (Brown and Shaw, 2003). Exper-
imental follow-up studies showed that YeeU suppresses the
toxicity of YeeV but only when expressed from a single plasmid
that contained the two genes in the same operon organization
found in the E. coli chromosome, that is, separated by
a 68 base pair intergenic untranslated region (UTR). The absence
of YeeV expression from a plasmid with this structure led to thel rights reserved
Structure
Homologies between Different Bacterial TA Systemsconclusion that YeeU acts as a transcription factor or translation
factor attenuating YeeV expression by interaction with this inter-
genic UTR (Brown and Shaw, 2003). This regulatory paradigm,
which does not involve a direct physical interaction between
the YeeU antitoxin and YeeV toxin, is fundamentally different
from that of the other well-characterized bacterial TA systems.
E. coli K12 encodes three additional proteins with strong amino
acid sequence similarity to YeeU: YafW (62% identical), YfjZ
(66% identical), and YagB (63% identical). Crystal and NMR
structures of YfjZ confirm that it has the same fold as YeeU
(PDB ID codes 2EA9 and 2JN7). The genes encoding YafW
and YfjZ are upstream of genes encoding proteins homologous
to YeeV (although these putative operons lack any equivalent
of the downstream yeeW gene of unknown function found in
the yeeUVW operon). YafW and YfjZ have both been demon-
strated to suppress the toxicity of the downstream YeeU homo-
logs encoded in their respective operons (Brown and Shaw,
2003), confirming that YeeU-family proteins generally have anti-
toxin activity.
A Dali search was used to generate clues concerning YeeU
function (Table 1). The structurally similar proteins identified in
this search include many with unknown functions as well as
some functioning in transcriptional regulation (e.g., E. coli TyrR,
PDB ID code 2JHE). The most striking result was the revelation
that YeeU has the same core fold as the YoeB (Kamada and
Hanaoka, 2005) and RelE (Li et al., 2009; Takagi et al., 2005)
nucleic acid-interacting toxins. The highest degree of structural
similarity to a known toxin is to the RelE toxin from Pyrococcus
horikoshii (PDB ID code 1WMI, Z score of 4.0 and 3.5 A˚ rmsd
for the alignment of 69 residues with 7% sequence identity)
(Figure 6B). However, there is also significant similarity to the
RelE toxins from E. coli, M. tuberculosis, and Methanococcus
jannaschii and to YoeB from E. coli (PDB ID code 2A6S, Z score
of 3.0 and 3.2 A˚ rmsd for the alignment of 61 residues with 7%
sequence identity) (Figure 6C). In all of these proteins, the
three-stranded b sheet and flanking a helix that form the struc-
tural core of YeeU (strands b3–5 and helix a1) align with equiva-
lent secondary structural elements that occur with identical
topology in the RelE/YoeB-family toxins (Figure 6). The structural
differences in these toxins compared to YeeU are all limited to
secondary structural elements on the edges of the central
three-stranded b sheet (which cause YeeU and RelE/YoeB to
be assigned different SCOP families). Structural elaborations of
this kind are routine in the course of protein evolution (Andreeva
andMurzin, 2006) and are consistent with the hypothesis that the
likely nucleic acid-binding antitoxin YeeU could share a common
evolutionary ancestry with nucleic acid-binding toxins from the
RelE/YoeB family.
YeeU May Bind Nucleic Acids at a Homologous Site
but Lacks Catalytic Residues from the Toxins
Previous studies have documented the structural similarity of
RelE and YoeB to the microbial RNases barnase and RNase
Sa (Kamada and Hanaoka, 2005; Takagi et al., 2005), as shown
in Figure S6 and reviewed briefly in Supplemental Information.
RelE has high-level RNase activity that mediates its cytotoxicity
(Christensen and Gerdes, 2003; Pedersen et al., 2003). Whereas
YoeB had demonstrated weak RNase activity in vitro (Kamada
and Hanaoka, 2005; Zhang and Inouye, 2009), its cytotoxicityStructure 18, 996–appears to be mediated primarily by noncovalent interaction
with 50S ribosomal subunits which blocks translation initiation
(Zhang and Inouye, 2009). All four of these proteins are believed
to bind target RNAs at an equivalent region on the exposed
surface of the homologous b sheets forming the structural core
of these domains (Figures 6B and 6C; Figure S6) (Kamada and
Hanaoka, 2005; Li et al., 2009; Takagi et al., 2005). Whereas a
cluster of likely RNA-interacting/hydrolyzing residues is strongly
conserved at these sites within each individual functional protein
family, these residues are generally not preserved between the
different functional families (Figure S6). For example, although
YoeB shares two of the four active-site residues conserved
between barnase and RNase Sa, neither of these residues is
found in the active site of RelE, which conserves just a single
arginine residue at an equivalent site compared to YoeB and no
residues compared to barnase or RNase Sa. (See Supplemental
Information for more details.)
A similar pattern of intrafamily amino acid conservation is
observed at the equivalent site on the surface of YeeU (Figure 6;
Figures S5 and S6). This region of YeeU contains a series of resi-
dues that are either invariant (Glu-81, Val-90, Thr-91, Thr-98,
Asp-102, and Ala-113) or strongly conserved (Gln-87, His-88,
and Tyr-115) among 20 YeeU homologs (including YafW and
YfjZ). A basic region of the protein surface immediately adjacent
to this site shows the strongest conservation of any segment of
YeeU (including residues Arg-33, Arg-47, Glu-81, and Tyr-111)
(Figure 6A; Figure S5). The stringent conservation of so many
charged and aromatic residues, which are overrepresented in
functional DNA-binding sites (Ades and Sauer, 1995), is consis-
tent with this region of YeeU mediating the functional regulatory
interactions with the intergenic UTR from YeeUV operon. The
structural similarity in this region between protein families with
widely diverged functions, as well as the strong amino acid
conservation within each family, are consistent with the hypoth-
esis that this surface forms a versatile nucleic acid-binding site
that has been adapted to mediate different kinds of nucleic
acid interactions over the course of bacterial evolution. Further
studies of the regulation of the expression of YeeV-family
proteins by YeeU-family proteins will be required to critically
evaluate this hypothesis.
Conclusion
Our results uncovered unanticipated structural similarity
between the components of disparate bacterial TA systems,
while also proving that earlier sequence-based predictions of
such similarity were indeed correct. Our crystal structure of
Phd definitively proves that there is homology in the DNA-
binding domains of antitoxins neutralizing toxins from the Doc,
RelE/YoeB, and FitB/VapC families, all three of which have
different protein folds (Figure 1). Although the relationship
between Phd and YefM was predicted from sequence-profiling
studies (Anantharaman and Aravind, 2003; Smith and Magnu-
son, 2004), proof that a single DNA-binding module has been
adapted for interaction with different toxin folds requiredmultiple
experimental structure determinations from many different
groups. Recent structural data on RelE toxins have proven that
multiple antitoxin folds are capable of neutralizing RelE/YoeB-
family toxins (Kamada and Hanaoka, 2005; Li et al., 2008; Takagi
et al., 2005). Our crystal structure of the HigA antitoxin extends1010, August 11, 2010 ª2010 Elsevier Ltd All rights reserved 1007
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Homologies between Different Bacterial TA Systemsthese results by establishing another antitoxin fold capable of
neutralizing these toxins.
Likewise, our structural results reveal latent structural
similarity between YeeU, which has an antitoxin-like activity,
and RelE/YoeB-family toxins. Therefore, these proteins seem
likely to share common evolutionary ancestry despite the
absence of detectable sequence similarity. Comparison of the
structure of YeeU to that of related toxin structures provides
insight into the antitoxin-like activity of YeeU by showing that
this nucleic acid-binding repressor has a similar fold to that of
the nucleic acid-binding toxins. Further biochemical studies
will be required to establish the exact mechanism by which
YeeU suppresses YeeV toxicity.
Our results demonstrate how evolutionary insights can
emerge from structure determination. Several of the relation-
ships between different TA systems discussed above would
likely have remained elusive in the absence of experimental
structural determinations. Structural studies thus provide
a powerful approach to uncovering new functional and evolu-
tionary relationships between protein families.
EXPERIMENTAL PROCEDURES
Phylogenetic Analyses of Eubacterial TA Systems
PSI-BLAST profiles (Altschul et al., 1997) were created for a set of canonical
toxin and antitoxin families in the CRSH database of proteins of likely equiva-
lent function from 474 fully sequenced bacterial genomes (Clusters of Recip-
rocal Sequence Homologs; http://www.orthology.org; S.K.H. and J.F.H.,
unpublished data). These profiles were used to identify families with significant
sequence similarity (e value < 103), which were combinedwith each other and
with other families with established structural similarity (Holm and Park, 2000)
to construct a new PSI-BLAST profile. This profile was used to identify the final
set of families in each group, according to the same significance criterion.
Cladograms were reconstructed by the program MEGA 3.0 (Kumar et al.,
2004) based on 100 bootstrap replicates using the UPGMAmethod (Legendre
and Legendre, 1998) with default parameters.
Cloning, Expression, and Purification
The Phd-Doc complex was cloned into pET21 with an LEHHHHHH affinity tag
at the C terminus of Doc. Sequencing of the Phd-Doc plasmid revealed that
there were mutations in three residues in the complex (L17M and V39A in
Phd and F68S in Doc). The relatively conservative Phd mutations occur at
partially solvent-exposed sites near the Phd homodimer interface and are
unlikely to alter its structure based on preservation of both protomer fold
and homodimer interactions in the EcYefM and NE2111 antitoxins
(Figure 3A). The Doc mutation is discussed in the text. Full-length EcYeeU
and SfYeeU were cloned in the same manner. The HigBA complex from
E. coli CFT073 was cloned into pET28 with an MGSSHHHHHHSSGLVPRGS
affinity tag at the N terminus of HigB. Recombinant proteins were expressed
in E. coli BL21l(DE3) using MJ9 minimal medium supplemented with seleno-
methionine (Jansson et al., 1996). The proteins were purified by Ni-NTA affinity
chromatography followed by gel filtration in 100 mM NaCl, 5 mM DTT, 10 mM
Tris (pH 7.5) (Benach et al., 2003). Phd-Doc, EcYeeU, SfYeeU, and HigBA are
Northeast Structural Genomics Consortium targets ER385/386, ER304,
SfR137, and ER389/390, respectively.
Protein Crystallization
Crystals of the Phd-Doc complex grew at 21C in 3 days to maximum dimen-
sions of 503 503 700 mm from 1+1 ml hanging-drop vapor-diffusion reactions
with the complex at 10.8 mg/ml over a 1 ml reservoir containing 2250 mM
NaCl, 100 mM NaH2PO4, 100 mM K2HPO4, 3% ethanol, 100 mM MES
(pH 6.5). Crystals of HigA, EcYeeU, and SfYeeU were all grown in 1:1 micro-
batch reactions under paraffin oil at 20C. HigA crystals grew in 1 day to
maximum dimensions of 20 3 40 3 200 mm after mixing the HigBA complex1008 Structure 18, 996–1010, August 11, 2010 ª2010 Elsevier Ltd Alat 0.6 mg/ml with 35% 1,6-hexanediol, 5 mM MgSO4, 50 mM Tris (pH 8.5).
EcYeeU crystals grew in 3 days to maximum dimensions of 50 3 50 3
200 mm after mixing the protein at 2 mg/ml with 20% PEG 4K, 0.1 M
MgSO4, 0.1 M MOPS (pH 7.0). SfYeeU crystals grew in 2 days to maximum
dimensions of 50 3 50 3 150 mm after mixing the protein at 2.2 mg/ml with
20% PEG 20K, 0.1 M KH2PO4, 0.1 M MES (pH 6.0). HigA and SfYeeU crystals
were frozen directly in liquid propane without cryoprotection, whereas
Phd-Doc and EcYeeU crystals were cryoprotected for 1 min in the corre-
sponding precipitant solution plus 15% glycerol.
Structure Determination Methods
Diffraction data from crystals at 100K were processed with DENZO and SCA-
LEPACK (Otwinowski and Minor, 1997). Data for Phd-Doc and HigA were
collected on beamline NE-CAT ID-4 at the Advanced Photon Source, whereas
data for YeeU were collected on beamline X4A at the National Synchrotron
Light Source. The complete Phd-Doc complex was solved by molecular
replacement with the program COMO (Jogl et al., 2001) using as a search
model the Doc subunit of the complex containing only the 21 residue neutral-
ization domain of Phd (PDB ID code 3DD7). The model was built using Coot
(Emsley and Cowtan, 2004) and refined with REFMAC (Murshudov et al.,
1997) including TLS parameters. The structure of HigA at physiological pH
was solved by molecular replacement with the program COMO (Jogl et al.,
2001) using as a search model a previously determined HigA structure at
low pH (PDB ID code 2ICP). The structures of EcYeeU andSfYeeUwere solved
using single-wavelength anomalous diffraction data. The program SOLVE
(Terwilliger and Berendzen, 1999) found four selenium sites for EcYeeU and
two for SfYeeU. The structures of HigA, EcYeeU, and SfYeeU models were
built with O (Jones et al., 1991) and refined with CNS (Brunger et al., 1998),
yielding excellent stereochemical parameters (Table 2).
Structure Superposition and Display
Figures were prepared with PyMOL (DeLano, 2002). Structural similarity
searches were performed with Dali (Holm et al., 2008). Electrostatic surface
potentials were calculated with GRASP (Nicholls et al., 1991) or UHBD (Davis
et al., 1991). Solvent-accessible surface area was calculated with PISA
(Krissinel and Henrick, 2007).ACCESSION NUMBERS
Atomic coordinates and structure factors for the crystal structures of the
Phd-Doc TA system from bacteriophage P1, the HigA antitoxin from Escheri-
chia coli CFT073, and YeeU antitoxins from E. coli K12 and Shigella flexneri
have been deposited in the Protein Data Bank under ID codes 3KH2, 2ICT,
2H28, and 2INW, respectively.SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and Supplemental Experimental
Procedures and can be found with this article online at doi:10.1016/j.str.2010.
04.018.
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Note Added in Proof
A crystal structure has just been reported of a Phd-Doc complex containing
a 4:1 ratio of Phd-to-Doc (Garcia-Pino et al. (2010). Cell 142, 101-111), consis-
tent with the heterogeneity in oligomeric state observed in the hydrodynamic
studies reported in this paper.l rights reserved
